Toronto, Ontario–(Newsfile Corp. – January 17, 2022) – Britannia Life Sciences Inc. (CSE: BLAB) (“Britannia”) is pleased to announce the signing of a Master Services Agreement (“Agreement”) with...Read more
Toronto, Ontario–(Newsfile Corp. – January 5, 2022) – Britannia Life Sciences Inc. (CSE: BLAB) (“Britannia”) is pleased to announce that it has entered into an agreement with the vendors of Advanced Development and...Read more
Britannia Completes “Go Public” Transaction via Reverse Takeover of Rise Life Sciences and Launches Britannia Life Sciences Inc.
TORONTO, Nov. 15, 2021 /CNW/ – Britannia Life Sciences Inc. (BLAB: CSE) (“Britannia”) is pleased to announce the successful completion of its “go public” transaction by way of a reverse take-over (the...Read more
The European Industrial Hemp Association (EIHA) has launched the largest human trial on the toxicological effects of trace amounts of THC in food products – but will it be enough to persuade regulators to approve full-spectrum CBD? With an...Read more
06 May 2021 — The Association for the Cannabinoid Industry (ACI) and Centre for Medicinal Cannabis (CMC) has estimated the cannabidiol (CBD) industry will generate £690 million (US$959 million) in annual sales for 2021. This figure...Read more